Overview

Rivastigmine as a Treatment for Methamphetamine Dependence

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
To study the effects of treatment with rivastigmine on craving produced by experimental administration of methamphetamine.
Phase:
Phase 1
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Methamphetamine
Rivastigmine